A study found that new monoclonal antibody drugs for Alzheimer's may slow cognitive impairment through boosting levels of a specific protein in the brain.
Read more https://www.sciencedaily.com/releases/2024/09/240911112040.htm
A study found that new monoclonal antibody drugs for Alzheimer's may slow cognitive impairment through boosting levels of a specific protein in the brain.
Read more https://www.sciencedaily.com/releases/2024/09/240911112040.htm